Inactive Instrument
Quest PharmaTech Inc Stock Toronto S.E.
Stocks
QPT
CA74836M1068
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 3.38M 2.4M 2.09M 1.95M 1.79M 229M 3.42M 22.95M 8.97M 114M 9.03M 8.83M 379M | P/E 2025 |
-3.29x | P/E 2026 | 1.18x |
|---|---|---|---|---|---|
| Enterprise Value | 4.37M 3.11M 2.7M 2.51M 2.31M 295M 4.42M 29.64M 11.59M 148M 11.66M 11.41M 489M | EV / Sales 2025 |
-
| EV / Sales 2026 | - |
| Free-Float |
83.12% | Yield 2025 * |
-
| Yield 2026 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 17/06/2004 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 01/01/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 17/06/2004 | |
J. Lievonen
CHM | Chairman | - | 05/07/2021 |
Jeffrey Shon
BRD | Director/Board Member | - | 05/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -15.38% | - | - | 2.4M | |
| +0.40% | -2.85% | +0.14% | +13.91% | 48B | |
| +6.03% | +5.22% | +420.33% | +519.87% | 41.13B | |
| -2.21% | -6.07% | +24.87% | +5.20% | 37.56B | |
| +2.94% | -2.25% | +6.15% | +59.69% | 35.91B | |
| +1.98% | +4.74% | +12.19% | +41.37% | 29.86B | |
| +0.47% | -3.87% | - | - | 16.12B | |
| +0.31% | +0.72% | +32.99% | +122.25% | 16.05B | |
| +0.61% | +0.87% | +3.96% | +17.92% | 13.76B | |
| -0.98% | -12.98% | -4.82% | -38.09% | 12.1B | |
| Average | +0.96% | -1.81% | +61.98% | +92.76% | 27.83B | |
| Weighted average by Cap. | +1.43% | -0.93% | +82.51% | +116.78% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | - | - |
| Net income | -1.8M -1.28M -1.11M -1.04M -952K -122M -1.82M -12.22M -4.78M -60.89M -4.81M -4.7M -202M | 5M 3.55M 3.09M 2.88M 2.64M 338M 5.05M 33.92M 13.26M 169M 13.34M 13.05M 560M |
| Net Debt | 795K 565K 491K 458K 420K 53.76M 804K 5.39M 2.11M 26.87M 2.12M 2.08M 89.04M | 986K 701K 608K 567K 521K 66.66M 996K 6.69M 2.61M 33.32M 2.63M 2.57M 110M |
Employees
-
